Showing results (71-80 of 78) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Hematological Oncology|February 13, 2014
Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patientsNaoto Tomita, Fumio Kodama, Naoko Tsuyama, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 15, 2015
[Analysis of prognostic factors in transplant-eligeble newly diagnosed myeloma patients treated with bortezomib plus dexamethasone as induction therapy]Hideyuki Koharazawa, Reina Watanabe, Yukako Hattori, et al.Leukemia Research|September 10, 2015
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Naoto Tomita, Masataka Taguri, et al.American Journal of Hematology|December 6, 2019
Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre-transplant conditioning using fludarabine, reduced-dose cyclophosphamide, and low-dose thymoglobulin: A KSGCT prospective studyShinichi Kako, Yoshinobu Kanda, Makoto Onizuka, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2014
Tamibarotene as maintenance therapy for acute promyelocytic leukemia: results from a randomized controlled trialKatsuji Shinagawa, Masamitsu Yanada, Toru Sakura, et al.Leukemia & Lymphoma|June 21, 2016
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphomaNaoto Tomita, Taisei Suzuki, Kazuho Miyashita, et al.Cell Reports. Medicine|May 24, 2021
Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection testsYutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, et al.Blood|October 25, 2021
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutationsTakahiko Yasuda, Masashi Sanada, Masahito Kawazu, et al.Pageof 8